From September 9, 2021 to October 31, 2021, the company has repurchased 0 shares, representing 0% for $0 million. With this, the company has completed the repurchase of 0 shares, representing 0% for $0 million under the buyback announced on September 9, 2021.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.01 CAD | +0.33% | +2.03% | -61.41% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-61.41% | 34.94M | |
-2.26% | 104B | |
+1.41% | 97.42B | |
+0.79% | 22.2B | |
-17.84% | 21.23B | |
-11.11% | 18.33B | |
-42.83% | 16.35B | |
-17.63% | 15.06B | |
+4.55% | 13.98B | |
+32.11% | 11.66B |
- Stock Market
- Equities
- BCT Stock
- News BriaCell Therapeutics Corp.
- Tranche Update on BriaCell Therapeutics Corp.'s Equity Buyback Plan announced on September 9, 2021.